Michael Jaff
Direktor/Vorstandsmitglied bei HEARTBEAM, INC.
Vermögen: 208 834 $ am 31.05.2024
Aktive Positionen von Michael Jaff
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HEARTBEAM, INC. | Direktor/Vorstandsmitglied | 24.07.2023 | - |
| Independent Dir/Board Member | 24.07.2023 | - | |
Embolitech LLC
 Embolitech LLC Miscellaneous Commercial ServicesCommercial Services Embolitech LLC provides thrombomatrix technology. The firm’s initial research areas focus on the removal of organized thrombi and emboli. It’s Thrombomatrix technology will redefine treatment of peripheral vascular emboli and thrombi. The company was founded by Gary Ansel and Michael R. Jaff in 2016 and is headquartered in Austin, TX. | Gründer | 01.01.2016 | - |
| Corporate Officer/Principal | 01.01.2016 | - | |
Access Vascular, Inc.
 Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michael Jaff
Ehemalige bekannte Positionen von Michael Jaff
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Michael Jaff
| Dickinson College | Undergraduate Degree |
| Kirksville College of Osteopathic Medicine, Inc. | Doctorate Degree |
| Harvard Business School | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEARTBEAM, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Embolitech LLC
Embolitech LLC Miscellaneous Commercial ServicesCommercial Services Embolitech LLC provides thrombomatrix technology. The firm’s initial research areas focus on the removal of organized thrombi and emboli. It’s Thrombomatrix technology will redefine treatment of peripheral vascular emboli and thrombi. The company was founded by Gary Ansel and Michael R. Jaff in 2016 and is headquartered in Austin, TX. | Commercial Services |
Access Vascular, Inc.
Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Health Technology |
- Börse
- Insiders
- Michael Jaff
- Erfahrung
